Oncimmune announces new contract with global pharma company
The contract concerns profiling Immunoglobulin E autoantibodies in blood serum
Read More
Tag: precision medicine
Researchers map interactions of 144 active substances to identify drug benefits
The study yielded over one million dose-responsive curves for existing cancer drugs
Read More
Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
The OptiZest study aims to investigate a personalised dose of Zestril in these patients
Read More
Exscientia expands translational capabilities with Allcyte acquisition
Allcyte specialises in artificial intelligence (AI) based precision medicine
Read More
Early promise for new immunotherapy combo in brain cancer
Experimental drug plus immunotherapy demonstrated early potential in aggressive brain cancer
Read More
ICR study combines precision medicines to treat drug-resistant cancers
Researchers found combination treatment showed promise against a range of cancer types
Read More
‘New era’ of precision medicine for children with cancer
only 7% of children with targetable mutations were able to access the appropriate adult drug in a study.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
